However, when OM-153 was dosed in the range of 0.1–10 mg/kg in combination with anti–PD-1 treatment, 51%–65% tumor end volume inhibition was documented when compared with the vehicle control (Fig. 5A; Supplementary Fig. S7A–S7C). This evidence concerns the gene PDCD1 and neoplasm.